China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Ltd. (HKSE: 3320) is trading at HK$4.36, about ₹53 at today's HKD/INR rate, as of 29 Sep 2026, 4:08 AM ET, up 0.11% today. Indian residents can buy China Resources Pharmaceutical from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$4.33
Today's high
HK$4.41
52 week low
HK$4.22
52 week high
HK$6.53
3320 opened at HK$4.33, closed previously at HK$4.36, and has traded between HK$4.22 and HK$6.53 over the past 52 weeks.
About
China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Key statistics
Avg. volume
8.94M
Market cap
HK$27.39B
P/E Ratio
5.81
Price-to-sales ratio
0.09
Enterprise value
HK$110.11B
Free cash flow yield
65.76%
Debt-to-equity ratio
1.87
Return on equity
7.92%
ROIC
4.08%
Beta
-0.40
Dividend yield
5.50%
Last dividend
HK$0.22
Financial overview
Revenue
HK$300.01B
Earnings per share
HK$0.72
Free cash flow
HK$18.83B
Net profit margin
1.53%
Gross margin
16.36%
EBITDA
HK$17.70B
Revenue growth
9.42%
Similar securities
This is not an investment recommendation
How to buy China Resources Pharmaceutical from India
Indian residents can buy China Resources Pharmaceutical shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for China Resources Pharmaceutical and place an order
Find China Resources Pharmaceutical by name or by its ticker, 3320, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. China Resources Pharmaceutical trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your China Resources Pharmaceutical position in HKD and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in China Resources Pharmaceutical from India
Trading and taxes when buying China Resources Pharmaceutical from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. China Resources Pharmaceutical’s current yield is 5.50%.Dividend tax explained
- Estate or inheritance tax
- May applyHong Kong has no estate duty.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy China Resources Pharmaceutical stock?
Yes. China Resources Pharmaceutical (3320) has been listed on the Hong Kong Stock Exchange since 2016, in the Medical - Pharmaceuticals industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one China Resources Pharmaceutical share cost in rupees?
One China Resources Pharmaceutical share is HK$4.36 — about ₹53 at an HKD/INR rate of 12.25 on 28 Sep 2026. Both the China Resources Pharmaceutical price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying China Resources Pharmaceutical from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of China Resources Pharmaceutical?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on China Resources Pharmaceutical shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the China Resources Pharmaceutical price. Paasa issues a capital-gains statement for your return.
Does China Resources Pharmaceutical pay a dividend, and how is it taxed in India?
Yes. China Resources Pharmaceutical pays a dividend and the current yield is 5.50%; the last declared dividend was HK$0.22 per share, about ₹2.67. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade China Resources Pharmaceutical from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is there estate or inheritance tax on China Resources Pharmaceutical shares held from India?
Hong Kong has no estate duty.
Do I have to declare China Resources Pharmaceutical shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your China Resources Pharmaceutical holding, its cost and its closing value.
How do I sell China Resources Pharmaceutical and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.